A combination of Nottingham prognostic index and IHC4 score predicts pathological complete response of neoadjuvant chemotherapy in estrogen receptor positive breast cancer-Reference-Cited by-全球学者库

A combination of Nottingham prognostic index and IHC4 score predicts pathological complete response of neoadjuvant chemotherapy in estrogen receptor positive breast cancer

Published:2016-11-24 Issue:52 Volume:7 Page:87312-87322
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Tan Weige¹²,Luo Wei¹,Jia Weijuan¹,Liang Gehao¹,Xie Xinhua³,Zheng Wenbo²,Song Erwei¹⁴,Su Fengxi¹,Gong Chang¹

Affiliation:

1. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation and Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China

2. Department of Breast Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

3. Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

4. Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University, Guangzhou, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modified IHC4 score predicts prognosis but not chemotherapy survival benefit in young women with HR-positive, HER2-negative early breast cancer: A Hospital-Based Cohort study;2023-12-23

2. A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer;Science China Life Sciences;2022-05-13

3. Pretreatment DCE-MRI-Based Deep Learning Outperforms Radiomics Analysis in Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer;Frontiers in Oncology;2022-03-10

4. Future Role of Molecular Profiling in Small Breast Samples and Personalised Medicine;A Comprehensive Guide to Core Needle Biopsies of the Breast;2022

5. Knockdown of the prognostic cancer stem cell marker Musashi-1 decreases radio-resistance while enhancing apoptosis in hormone receptor-positive breast cancer cells via p21WAF1/CIP1;Journal of Cancer Research and Clinical Oncology;2021-07-22